CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (unaudited) - USD ($)
$ in Thousands |
3 Months Ended |
Apr. 30, 2016 |
Apr. 30, 2015 |
| Cash flows from operating activities: |
|
|
| Net (loss) income |
$ (2,742)
|
$ 549
|
| Adjustments to reconcile net (loss) income to net cash provided by operating activities: |
|
|
| Depreciation and amortization |
1,476
|
1,454
|
| Provision for doubtful accounts and sales adjustments |
49
|
311
|
| Stock compensation expense |
1,554
|
1,306
|
| Change in fair value of derivative instrument |
31
|
(245)
|
| Excess tax benefits from share-based payment arrangements |
(222)
|
(151)
|
| Changes in assets and liabilities: |
|
|
| Accounts receivable |
21,430
|
26,823
|
| Other assets |
(2,960)
|
(1,122)
|
| Accounts payable |
(3,151)
|
(4,456)
|
| Deferred revenue |
(7,480)
|
(11,157)
|
| Other liabilities |
(6,850)
|
(8,976)
|
| Net cash provided by operating activities |
1,135
|
4,336
|
| Cash flows from investing activities: |
|
|
| Purchase of property and equipment |
(1,074)
|
(1,140)
|
| Capitalized software costs |
(12)
|
(28)
|
| Net cash used in investing activities |
(1,086)
|
(1,168)
|
| Cash flows from financing activities: |
|
|
| Repayments of debt |
(106)
|
(102)
|
| Tax payments, net of proceeds, related to stock awards |
(369)
|
(391)
|
| Payment of contingent liability associated with acquisitions |
0
|
(750)
|
| Excess tax benefits from share-based payment arrangements |
222
|
151
|
| Proceeds from issuance of common stock, net of issuance of costs |
0
|
8,365
|
| Net cash (used in) provided by financing activities |
(253)
|
7,273
|
| Effect of exchange rates on cash and equivalents |
2,351
|
(103)
|
| Net increase in cash and equivalents |
2,147
|
10,338
|
| Cash and equivalents at beginning of period |
137,731
|
120,526
|
| Cash and equivalents at end of period |
139,878
|
130,864
|
| Supplemental disclosure of non-cash activities: |
|
|
| Obligations associated with dividend declaration |
$ 1,316
|
$ 1,299
|